INTRODUCTION
Thirty years into the HIV/AIDS epidemic, HIVrelated stigma remains an ongoing challenge and a growing priority for intervention. 1, 2 People living with HIV (PLWH) who experience high perceptions of HIV-related stigma are less likely to disclose their status [3] [4] [5] ; they report more psychological distress 6, 7 and lower social support 8, 9 than those with lower perceptions of HIV-related stigma. Stigma also has been associated with some outcomes along the HIV care continuum. Those who hold more stigmatizing attitudes toward PLWH are less likely to undergo HIV testing themselves, [10] [11] [12] [13] [14] [15] and high perceived stigma among those in HIV care is associated with poorer antiretroviral therapy (ART) adherence. 16 However, evidence on whether stigma influences other care continuum outcomes is limited. [17] [18] [19] [20] [21] [22] [23] As conceptualized by Earnshaw and Chaudoir, 24 stigma processes and outcomes differ between PLWH, who may experience stigma around being HIV-infected, and those who are HIV-negative (or do not know their status), who may hold stigmatizing views of PLWH. Among PLWH, stigma comprises 3 domains-internalized, anticipated, and enacted stigma. Few studies have examined the relationship of each of these domains to care-related outcomes. Understanding how stigma processes may influence outcomes across the HIV care continuum is important for guiding interventions to achieve the UNAIDS 90-90-90 targets, especially in sub-Saharan Africa, where significant gaps have been reported. [25] [26] [27] We used data from Ethiopian adults newly initiating ART to explore associations between stigma and important care-related outcomes. We hypothesized that higher stigma would be associated with indicators of delay in HIV testing and/or care enrollment/ART initiation, and sporadic use of care once enrolled/initiated on ART.
In Ethiopia, HIV prevalence declined between 2005 to 2013 (estimated 1.2% in adults), but in 2013 there were still 590,000 adult PLWH, only 50% of whom were receiving ART. 28 HIV stigma indicators in 2011 were in the mid-range of sub-Saharan countries, with 17.1% of women and 27.6% men holding stigmatizing views. 29 
METHODS

Participants and Data Sources
Data were drawn from a cross-sectional and prospective study of late initiation of ART described previously. 30 PLWH $18 years of age newly initiating ART between June 2012 and April 2013 at 6 HIV clinics in Oromia, Ethiopia, were eligible for inclusion. The sites were secondary health facilities in urban areas and receiving support from ICAP at Columbia University with funding from the U.S. President's Emergency Plan for AIDS Relief.
Clinic providers referred eligible patients to study staff on the day of ART initiation. Those interested in study participation provided written informed consent and completed a 45-minute structured interview within 2 weeks of ART initiation; participants received 20 birr (;1 USD) upon interview completion. Interview data were linked to an existing database that captured routinely collected clinical data on patients from the date of their enrollment in that clinic (or the date of their HIV-positive test if done at that clinic) up to 12 months after ART initiation. Data were deidentified before analysis. Ethical approval was obtained from the Oromia Regional Health Bureau, Columbia University, and the City University of New York.
Measures Exposures
Internalized Stigma
Internalized stigma was assessed with the 5-item negative self-perception subscale of the HIV/AIDS Stigma Instrument, PLWHA (HASI-P), 31 developed in sub-Saharan Africa. Items inquired how often over the previous 3 months participants, for example, felt that you did not deserve to live, that you were no longer a person, with response options ranging from Never (4) to Most of the time (1) An additional item not from this scale (You thought someone had cursed you) also was included (Cronbach's alpha = 0.95). Scores were recoded so that higher scores represented higher internalized stigma. Because summary responses were skewed (mean = 1.55, median = 1.33), we categorized them into tertiles.
Anticipated Stigma
Anticipated stigma was assessed with 12 items following the concept described by Earnshaw and Chaudoir, 24 using the stem, Do you think the following could happen if others know or suspect you are HIV-positive (eg, your partner might get violent; your children might be abused or discriminated against; family members might treat you differently), with yes/no response options (Cronbach's alpha = 0.76). A total anticipated stigma score was constructed as the proportion of endorsed items from among all questions the participant was eligible to answer (ie, participants without children or without a partner were not eligible to answer those items), and the score was categorized into tertiles.
Enacted Stigma
Enacted stigma was measured with 9 items selected from HASI-P 31 subscales (verbal abuse, fear of contagion, and social isolation); items inquired how often in the prior 3 months the participant had experienced rejection because of his/her HIV status (eg, You were told that you have no future, You were told that God is punishing you, Someone stopped being your friend), with response options ranging from Never (4) to Most of the time (1) (Cronbach's alpha = 0.99). Because the reported occurrence of all items was low, the summary measure was re-coded as any vs. none.
HIV Care Continuum Outcomes
Outcomes included 6 care-related indicators that were ascertained in the study and thought potentially to be influenced by stigma: (1) a repeat HIV+ test before enrolling in care, a possible indicator of delayed enrollment; (2) provider-vs. self-initiated testing, a possible indicator of delayed diagnosis; (3) a missed clinic visit before ART initiation; (4) eagerness vs. reluctance to initiate ART; (5) late ART initiation (initiating ART with advanced disease); and (6) $3-month gap in care after ART initiation.
By interview, participants were asked the date of their most recent HIV-positive test, and if they had previously tested HIV-positive; those who did were characterized as having a repeat HIV-positive test. For this variable, we excluded 349 participants for whom it was not possible to determine which test occurred first or if they reported a test date after their HIV clinic enrollment date. To determine who initiated testing, participants were asked if they sought the test on their own, or it was offered by a provider including as part of PMTCT services. They were additionally asked if they had missed a clinic visit before initiating ART (ever/never), and about their eagerness to start ART [5 response options dichotomized into (somewhat/very eager) vs. (somewhat/very reluctant or neither reluctant nor eager)]. Outcomes ascertained from electronic medical record data were late ART initiation, defined as CD4 + count ,150 cells/mL or WHO stage IV at ART initiation, 30 and a gap in HIV care of 3 months or more in the year after ART initiation. Participants (N = 146) who had no opportunity to experience a 3-month gap in care because they were lost to follow-up, transferred out, or had died before 3 months on ART were excluded from this variable.
Potential Confounders
Time from diagnosis in months was ascertained from the earliest self-reported date of HIV-positive test or the diagnosis date noted in the medical record to date of interview. Other measures examined as potential confounders were age, gender, education, religion, relationship status, widowhood, residence location (rural/urban), employment status, and food insecurity.
Statistical Analyses
Pairwise correlations between stigma domain measures were assessed with Spearman correlation coefficients. Bivariate associations between stigma and potential confounders were evaluated using x 2 statistics for categorical variables, and Mann-Whitney U and Kruskal Wallis tests for skewed continuous data. Logistic regression was used to model change in the log odds of each care continuum outcome associated with high and medium vs. low stigma in each domain (or any vs. no enacted stigma). Time from diagnosis was included a priori as a confounder because it could be associated with lower stigma and poorer care continuum outcomes. Other potential confounders that were significantly associated with stigma and altered the crude estimate of association were retained in the adjusted models.
RESULTS
Description of the Population
Of 1180 study participants, clinical data for up to 1 year following ART initiation was available for 1179. As described above, 831 were available for analysis of repeat HIV-positive testing, and 1033 participants were available for analysis of a 3-month gap in care following ART initiation. Among the 1180, mean age was 34 years, interquartile range (IQR) 28-40; the median length of time since diagnosis was 8.3 months (IQR: 1.1 months-3.4 years). Median time since enrollment in care was 2.9 months (IQR: 15 days-2.6 years). Other sample characteristics are shown in Table 1 .
The mean internalized stigma score was 1.55 (SD: 0.57); the median was 1.33 (IQR: 1-2) (possible range: 1-4) ( Table 1 ). The mean anticipated stigma score was 26.9 (SD: 
Anticipated Stigma
Higher levels of anticipated stigma were significantly associated with higher odds of a repeat HIV-positive test (vs. 1 HIV-positive test) (aOR medium vs. low : 1.9; 95% CI: 1.1 to 3.2); and lower odds of being eager (vs. reluctant) to begin ART (aOR high vs. low : 0.55; 95% CI: 0.35 to 0.87; aOR medium vs. low : 0.45; 95% CI: 0.30 to 0.69). Anticipated stigma was not associated with provider-vs. self-initiated test, a missed visit before ART initiation, late ART initiation, or a 3-month gap in care following ART initiation.
Enacted Stigma
Experiencing any vs. no enacted stigma was significantly associated with higher odds of a repeat HIV-positive test (vs. 1 HIV-positive test) (aOR: 1.9; 95% CI: 1.1 to 3.2), and higher odds of a missed visit before ART initiation (aOR: 1.8; 95% CI: 1.2 to 2.8). Enacted stigma was not associated with any of the other outcomes. In logistic regression (OR, aOR estimates), the modeled outcome category is italicized in the top row. Models adjusted for time since diagnosis, relationship status, employment status, and food security. Each stigma-specific model is separate (ie, other types of stigma were not adjusted for).
DISCUSSION
In a large population of PLWH initiating ART in Ethiopia, measures of internalized, anticipated, and enacted stigma were associated with several outcomes across the HIV care continuum: high internalized stigma with a provider-vs. a self-initiated HIV-test, possibly indicating delayed testing; higher internalized and anticipated stigma with repeat testing after an HIV-positive result, possibly indicating delayed enrollment in care; higher anticipated stigma with reluctance to initiate ART; and enacted stigma with missing a clinic visit before ART initiation.
These findings support emerging evidence that beyond reducing ART adherence, stigma influences other care continuum outcomes. Although data were collected before the most recent expansion of ART access, the study encompassed a period of expanding access. 30 A limitation is that temporality cannot be established for the associations of stigma with repeat testing and provider-vs. self-initiated testing, as these outcomes were ascertained concurrently with stigma but they occurred earlier. Additionally, repeat testing and provider-initiated testing are only potential indicators of delayed testing and delayed enrollment in care. It is notable, however, that higher anticipated stigma, assessed close in time to ART initiation, was associated with greater reluctance to initiate. We are unsure why no stigma measure was associated with late ART initiation, but this outcome has multiple causes. 30 Finally, the population in this study was restricted to those initiating ART, thereby excluding those lost at earlier stages of the care continuum. Overall, scores on stigma measures were low, especially enacted stigma, for which only 16% of participants reported an event. Although internalized and enacted stigma were assessed with reliable scales developed in sub-Saharan Africa, 31 they may lack sensitivity for some outcomes. Further, anticipated stigma was newly developed and had acceptable but lower internal consistency reliability (a = 0.76) than the other stigma measures.
Despite these limitations, our study had several strengths: the large sample size, the distinct domains of stigma assessed, and the range of outcomes examined. The findings provide further support for the importance of investigating and addressing stigma across the entire HIV care continuum, especially given the need for effective stigma reduction interventions. 32, 33 Future research should examine care continuum outcomes before ART initiation, refine the anticipated stigma measure, and assess specific hypotheses about the association of each measure with important HIV care continuum outcomes prospectively, or in the context of an intervention.
